论文部分内容阅读
急性粒细胞性白血病(以下简称急粒)为造血系统常见的恶性肿瘤,多发生于青壮年,是危及广大劳动人民健康的严重疾病。近年来,由于对急性白血病进行了较广的研究,对肿瘤细胞动力学有了进一步认识,加之新的化疗药物不断出现,改进了治疗方案,加强了支持疗法等综合措施,使急性白血病的缓解率有所提高。我们自1971年把喜树碱应用于临床,治疗多种恶性肿瘤和白血病,现仅就对“急粒”的疗效观察,初步报导如下。
Acute myeloid leukemia (hereinafter referred to as acute grain) is a common malignant tumor of hematopoietic system, which occurs mostly in young adults and is a serious disease endangering the health of working people. In recent years, due to a wider study of acute leukemia, further understanding of tumor cell kinetics, coupled with the emergence of new chemotherapeutic drugs, improved treatment options, and strengthen the supportive measures and other comprehensive measures to acute leukemia remission Rate has improved. We have since 1971 applied to the clinical application of camptothecin, a variety of malignant tumors and leukemia, are only on the “acute particles” effect, initially reported as follows.